157 related articles for article (PubMed ID: 35618971)
21. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
22. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.
Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ
J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190
[TBL] [Abstract][Full Text] [Related]
23. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
24. CD44 isoform expression in periodontal tissues: cell-type specific regulation of alternative splicing.
Hirano F; Hirano H; Hino E; Takayama S; Saito K; Kusumoto Y; Shimabukuro Y; Murakami S; Okada H
J Periodontal Res; 1997 Nov; 32(8):634-45. PubMed ID: 9409458
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression.
Raso-Barnett L; Banky B; Barbai T; Becsagh P; Timar J; Raso E
PLoS One; 2013; 8(1):e53883. PubMed ID: 23342032
[TBL] [Abstract][Full Text] [Related]
26. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
[TBL] [Abstract][Full Text] [Related]
27. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
28. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
29. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.
David G; Reboutier D; Deschamps S; Méreau A; Taylor W; Padilla-Parra S; Tramier M; Audic Y; Paillard L
Biochem Biophys Res Commun; 2022 Oct; 626():79-84. PubMed ID: 35973378
[TBL] [Abstract][Full Text] [Related]
30. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
31. Alternative exon-specific PCR method for the analysis of human CD44 isoform expression.
Lockhart MS; Gravisaco MJ; Mongini C; Waldner C; Alvarez E; Hajos SE
Oncol Rep; 1999; 6(1):219-24. PubMed ID: 9864432
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44.
Chiu RK; Carpenito C; Dougherty ST; Hayes GM; Dougherty GJ
Neoplasia; 1999 Nov; 1(5):446-52. PubMed ID: 10933060
[TBL] [Abstract][Full Text] [Related]
34. Nuclear hyaluronidase 2 drives alternative splicing of
Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
[TBL] [Abstract][Full Text] [Related]
35. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
36. Alternative CD44 splicing in intestinal stem cells and tumorigenesis.
Guo W; Frenette PS
Oncogene; 2014 Jan; 33(5):537-8. PubMed ID: 23831568
[TBL] [Abstract][Full Text] [Related]
37. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
38. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
[TBL] [Abstract][Full Text] [Related]
39. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
40. CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
Rajarajan A; Stokes A; Bloor BK; Ceder R; Desai H; Grafström RC; Odell EW
PLoS One; 2012; 7(1):e28776. PubMed ID: 22242150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
